title: Radiation recall with vinorelbine and cisplatin.
abstract: BACKGROUND
  Radiation recall dermatitis (RRD) is an inflammatory skin reaction in a previously irradiated field in response to certain pharmacological agents. Little is known about the potential risk of RRD in response to the use of vinorelbine and cisplatin.
  
  
  METHODS
  Herein, we report a case of RRD following the combination treatment of vinorelbine and cisplatin in a lung cancer patient with lymph node metastasis. We describe the timing and doses of radiation exposure and chemotherapy, the features of the skin reactions, the clinical management, and the outcome. We also review previous reports on RRD to explain the characteristics of the reaction and the potential mechanisms.
  
  
  CONCLUSIONS
  Clinical health care professionals should be aware of the possibility of a recall reaction whenever vinorelbine and cisplatin are used, although the frequency is probably low.
authors.affiliation: Department of Radiation Oncology, Fudan University Cancer Hospital, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
authors.forename: Zheng-Fei
authors.initials: ZF
authors.lastname: Zhu
authors.forename: Min
authors.initials: M
authors.lastname: Fan
authors.forename: Xiao-Long
authors.initials: XL
authors.lastname: Fu
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy*; D008875:Middle Aged; D011855:Radiodermatitis / Q000139:chemically induced* / Q000175:diagnosis; D020266:Radiotherapy, Conformal / Q000009:adverse effects*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine